Onken, J. E., Sands, B., Hogezand, R., Haens, G., Braakman, T., DeWoody, K., … Present, D. (1999). Consistent treatment benefit with infliximab in patients with fistulizing Crohn's disease. GASTROENTEROLOGY, 116(4), A788–A788.

Onken, J. E., B. Sands, R. Hogezand, G. Haens, T. Braakman, K. DeWoody, T. Schaible, et al. “Consistent treatment benefit with infliximab in patients with fistulizing Crohn's disease.” GASTROENTEROLOGY 116, no. 4 (April 1, 1999): A788–A788.

Onken JE, Sands B, Hogezand R, Haens G, Braakman T, DeWoody K, et al. Consistent treatment benefit with infliximab in patients with fistulizing Crohn's disease. GASTROENTEROLOGY. 1999 Apr 1;116(4):A788–A788.

Onken, J. E., et al. “Consistent treatment benefit with infliximab in patients with fistulizing Crohn's disease.” GASTROENTEROLOGY, vol. 116, no. 4, W B SAUNDERS CO-ELSEVIER INC, Apr. 1999, pp. A788–A788.

Onken JE, Sands B, Hogezand R, Haens G, Braakman T, DeWoody K, Schaible T, Targon S, Hanauer S, van Deventer S, Rutgeerts P, Present D. Consistent treatment benefit with infliximab in patients with fistulizing Crohn's disease. GASTROENTEROLOGY. W B SAUNDERS CO-ELSEVIER INC; 1999 Apr 1;116(4):A788–A788.